Alison L. Hannah
Board Member
Neogenomics Inc (NEO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
CytomX Therapeutics, Inc. (CTMX)
Proxy statement
Start not stated–2022-09-30
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President and Chief Medical Officer | $464,400 | $1,707,176 |
| 2020 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President and Chief Medical Officer | $412,500 | $1,677,988 |
| 2019 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President and Chief Medical Officer | — | — |
| 2018 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President and Chief Medical Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.